Erratum: Identification and characterization of novel sequence variations in the cytochrome P4502D6 (CYP2D6) gene in African Americans

被引：0
|
作者：
A Gaedigk
A Bhathena
L Ndjountché
R E Pearce
S M Abdel-Rahman
S W Alander
L DiAnne Bradford
J Steven Leeder
机构：
来源：
The Pharmacogenomics Journal | 2005年 / 5卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Correction to: The Pharmacogenomics Journal (2005) 5, 173–182. doi:10.1038/sj.tpj.6500305 The authors wish to add an additional co-author as indicated in bold: A Gaedigk, A Bhathena, L Ndjountché, RE Pearce, SM Abdel-Rahman, SW Alander, L DiAnne Bradford, PK Rogan3 and J Steven Leeder With the following affiliation: 3 Laboratory of Human Molecular Genetics, Children's Mercy Hospital & Clinics, Kansas City, MO, USA.
引用
收藏
页码：276 / 276
相关论文
共 50 条
  • [31] CYTOCHROME P4502D6 GENOTYPE DOES NOT DETERMINE RESPONSE TO CLOZAPINE
    ARRANZ, MJ
    DAWSON, E
    SHAIKH, S
    SHAM, P
    SHARMA, T
    AITCHISON, K
    CROCQ, MA
    GILL, M
    KERWIN, R
    COLLIER, DA
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 39 (04) : 417 - 420
  • [32] Metoprolol metabolism via cytochrome P4502D6 in ethnic populations
    Johnson, JA
    Burlew, BS
    DRUG METABOLISM AND DISPOSITION, 1996, 24 (03) : 350 - 355
  • [33] Discovery of a novel nonfunctional cytochrome P450 2D6 allele, CYP2D6*42, in African American subjects
    Gaedigk, A
    Ndjountché, L
    Gaedigk, R
    Leeder, JS
    Bradford, LD
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (06) : 575 - 576
  • [34] Cytochrome P450-2D6 (CYP2D6) genotypes in normal controls
    de Leon, J
    Rogers, T
    Brumagen, J
    Weddle, L
    Wedlund, PJ
    Chou, WH
    BIOLOGICAL PSYCHIATRY, 1998, 43 : 47S - 47S
  • [35] Correlation between cytochrome P-450CYP2D6 CYP2D6) genotype and phenotype
    Chen, SQ
    Wedlund, PJ
    ACTA PHARMACOLOGICA SINICA, 1999, 20 (07): : 585 - 588
  • [36] Variability in the frequency of cytochrome P450-2D6 (CYP2D6) deficiency
    Mörike, K
    Platten, HP
    Mikus, G
    Klotz, U
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 46 (01) : 87 - 87
  • [37] CYP2D6 gene polymorphism and enzyme activity in African Americans in Southern California.
    Wan, YJY
    Poland, RE
    Han, G
    Konishi, T
    Zheng, YP
    Lin, KM
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (02) : P71 - P71
  • [38] Duloxetine is both an inhibitor and a substrate of cytochrome P4502D6 in healthy volunteers
    Skinner, MH
    Kuan, HY
    Pan, A
    Sathirakul, K
    Knadler, MP
    Gonzales, CR
    Yeo, KP
    Reddy, S
    Lim, M
    Ayan-Oshodi, M
    Wise, SD
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (03) : 170 - 177
  • [39] Cellular epitope mapping of cytochrome P4502D6 in patients with autoimmune hepatitis
    Ma, Y
    Bogdanos, DP
    Williams, R
    Mieli-Vergani, G
    Vergani, D
    JOURNAL OF HEPATOLOGY, 2001, 34 : 212 - 212
  • [40] Identification of CYP2D6 impaired functional alleles in Mexican Americans
    Huai-Rong Luo
    Andrea Gaedigk
    Vasileios Aloumanis
    Yu-Jui Yvonne Wan
    European Journal of Clinical Pharmacology, 2005, 61 : 797 - 802
12345